Their plan follows successful tests of a similar vaccine against SIV - also known as simian HIV - in monkeys.
"We said 'let's use HIV against itself', and that's what we're doing," New Scientist quoted Gary McGarrity, VIRxSYS's vice president of scientific & clinical affairs, as saying.
VIRxSYS researchers described how they vaccinated monkeys, & then six months later injected them with SIV.Within weeks of receiving the injection of SIV, concentrations of the virus had fallen by at least 95% in those treated.
After a year, when the trial ended, these concentrations remained low, whereas untreated monkeys became progressively sicker as their immune systems were depleted by the virus.
What's more, in vaccinated animals, concentrations of CD4+ cells - the immune cells that both HIV & SIV attack & kill - remained the same, suggesting their immune systems were able to withstand SIV infection.
The findings 've been presented at the 2010 annual Conference on Retroviruses & Opportunistic Infections in San Francisco.
No comments:
Post a Comment